Factors associated with HIV/syphilis co-infection initiating of antiretroviral therapy

Authors

  • Luana Andrade Simões Universidade Federal de Minas Gerais. Faculdade de Farmácia. Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica. Belo Horizonte, MG, Brasil https://orcid.org/0000-0002-4942-5195
  • Jullye Campos Mendes Universidade Federal de Minas Gerais. Faculdade de Farmácia. Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica. Belo Horizonte, MG, Brasil https://orcid.org/0000-0003-3505-4626
  • Micheline Rosa Silveira Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil https://orcid.org/0000-0001-7002-4428
  • André Moura Gomes da Costa Universidade Federal de Minas Gerais. Faculdade de Engenharia. Programa de Pós-Graduação em Engenharia Elétrica. Belo Horizonte, MG, Brasil https://orcid.org/0000-0003-4936-8650
  • Mariana Dias Lula Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil https://orcid.org/0000-0003-0760-4424
  • Maria das Graças Braga Ceccato Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil https://orcid.org/0000-0002-4340-0659

DOI:

https://doi.org/10.11606/s1518-8787.2022056003904

Keywords:

HIV Infections, Syphilis, Coinfection, epidemiology, Risk Factors, Antiretroviral Therapy, Highly Active, Cross-Sectional Studies

Abstract

OBJECTIVE To evaluate the prevalence and factors associated with HIV/syphilis co-infection in people initiating antiretroviral therapy in Belo Horizonte, capital of the state of Minas Gerais. METHODS A sectional section of a prospective cohort study was carried out with people living with HIV, treatment-naive, initiating antiretroviral therapy, older than 16 years, and in follow-up treatment at specialized HIV/Aids care services in Belo Horizonte. Sociodemographic, behavioral, clinical, laboratory and pharmacological treatment-related data were obtained through interviews, medical records, and information systems for logistical control of antiretroviral medications and laboratory tests. The dependent variable was the first episode of active syphilis, recorded by the physician in clinical records, within 12 months after beginning of the antiretroviral therapy. Factors associated with HIV/syphilis co-infection were assessed using binary multiple logistic regression. RESULTS Among the 459 individuals included, a prevalence of 19.5% (n = 90) of sexually transmitted infections (STI) was observed, with syphilis (n = 49) being the most frequent STI in these individuals. The prevalence of HIV/syphilis co-infection was 10.6% (n = 49), and the associated independent factors were alcohol use (OR = 2.30; 95%CI: 1.01–5.26), and having a diagnosis of other sexually transmitted infections (OR = 3.33; 95%CI: 1.24–8.95). CONCLUSIONS There was a high prevalence of HIV/syphilis co-infection in people living with HIV initiating antiretroviral therapy in Belo Horizonte. HIV/syphilis co-infection was associated with behavioral and clinical factors, such as alcohol use and diagnosis of other sexually transmitted infections. Prior knowledge about the factors associated with this co-infection may support the decisions of health professionals engaged in the care to people living with HIV, with regard to timely diagnosis, guidance, follow-up and adequate treatment, both for syphilis and HIV.

References

World Health Organization. Report on global sexually transmitted infection surveillance, 2018. Geneva (CH): WHO; 2018 [cited 2021 May 25]. Available from: https://www.who.int/reproductivehealth/publications/stis-surveillance-2018/en/

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis (IST). Brasília, DF; 2020 [cited 2021 May 25]. Available from: http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrizes-terapeuticas-para-atencao-integral-pessoas-com-infeccoes

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Bol Epidemiol Sífilis. 2020;Nº Espec. [cited 2021 May 25]. Available from: http://www.aids.gov.br/pt-br/pub/2020/boletim-sifilis-2020

Mora Y, Mago H, Díaz I. Coinfección VIH-sífilis en pacientes con diagnóstico reciente de infección por virus de inmunodeficiencia humana, octubre 2018 - mayo 2019, Unidad de Infectología. Ciudad Hospitalaria Dr. Enrique Tejera. Bol Venez Infectol. 2019 [cited 2021 May 25];30(2):116-21. Available from: https://docs.bvsalud.org/biblioref/2019/11/1024096/05-mora-y-116-121.pdf

Santos OP, Souza MR, Borges CJ, Noll M, Lima FC, Barros PS. Hepatites B, C e sífilis: prevalência e características associadas à coinfecção entre soropositivos. Cogitare Enferm. 2017;22(3):e51693. https://doi.org/10.5380/ce.v22i3.51693

Luppi CG, Gomes SEC, Silva RJC, Ueno AM, Santos AMK, Tayra A, et al. Fatores associados à coinfecção por HIV em casos de sífilis adquirida notificados em um Centro de Referência de Doenças Sexualmente Transmissíveis e Aids no município de São Paulo, 2014. Epidemiol. Serv. Saúde. 2018;27(1):e20171678. https://doi.org/10.5123/s1679-49742018000100008

Ferreira-Júnior OC, Guimarães MDC, Damacena GN, Almeida WS, Souza-Júnior PRB, Szwarcwald CL; Brazilian FSW Group. Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016. Medicine (Baltimore). 2018;97(1Suppl):S3-8. https://doi.org/10.1097/MD.0000000000009218

Amorim LT, Schlemper Jr BR. HIV/AIDS in small cities in Midwest Santa Catarina, south of Brazil: clinical and epidemiological aspects, opportunistic infections. Rev Soc Bras Med Trop. 2019;52:e20180430. https://doi.org/10.1590/0037-8682-0430-2018

Silva BEB, Santos VS, Santos IER, Batista MVA, Gonçalves LLC, Lemos LMD. Prevalence of co-infections in women living with human immunodeficiency virus in Northeast Brazil. Rev Soc Bras Med Trop. 2020;53:e20190282. https://doi.org/10.1590/0037-8682-0282-2019

Weng RX, Hong FC, Yu WY, Cai YM. Compare HIV/syphilis infections between age groups and explore associated factors of HIV/syphilis co-infections among men who have sex with men in Shenzhen, China, from 2009 to 2017. PLoS One. 2019;14(10):e0223377. https://doi.org/10.1371/journal.pone.0223377

Liu Y, Tang HF, Ning Z, Zheng H, He N, Zhang YY. [Co-infections of HIV, syphilis and HSV-2 among men who have sex with men at the voluntary HIV counseling and testing clinics in Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(10):1363-6. Chinese. https://doi.org/10.3760/cma.j.issn.0254-6450.2017.10.013

Mutagoma M, Nyirazinyoye L, Sebuhoro D, Riedel DJ, Ntaganira J. Syphilis and HIV prevalence and associated factors to their co-infection, hepatitis B and hepatitis C viruses prevalence among female sex workers in Rwanda. BMC Infect Dis. 2017;17(1):525. https://doi.org/10.1186/s12879-017-2625-0

Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19 [cited 2021 May 25]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm

Joint United Nations Programme on HIV/AIDS. Global AIDS update 2020 Geneva (CH): UNAIDS; 2020 [cited 2021 Dec 1]. Available from: https://unaids.org.br/estatisticas/

Katamba C, Chungu T, Lusale C. HIV, syphilis, and hepatitis B co-infections in Mkushi, Zambia: a cross-sectional study. F1000 Res. 2019;8:562. https://doi.org/10.12688/f1000research.17983.2

Jansen K, Thamm M, Bock CT, Scheufele R, Kücherer C, Muenstermann D, et al. High prevalence and high incidence of co-infection with hepatitis B, hepatitis C, and syphilis and low rate of effective vaccination against hepatitis B in HIV-positive men who have sex with men with known date of HIV seroconversion in Germany. PLoS One. 2015;10(11):e0142515. https://doi.org/10.1371/journal.pone.0142515

Schuelter-Treviso F, Custódio G, Silva ACB, Oliveira MB, Wolfart A, et al. HIV, hepatitis B and C, and syphilis prevalence and co-infection among sex workers in Southern Brazil. Rev Soc Bras Med Trop. 2013;46(4):493-7. https://doi.org/10.1590/0037-8682-1364-2013

Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DH, Grewal R, et al. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis. 2015;15:356. https://doi.org/10.1186/s12879-015-1098-2

Zhang C, Ren Q, Chang W. Epidemiological features and risk factors for acquiring hepatitis B, hepatitis C, and syphilis in HIV-infected patients in Shaanxi Province, Northwest China. Int J Environ Res Public Health. 2020;17(6):1990. https://doi.org/10.3390/ijerph17061990

Remis RS, Liu J, Loutfy MR, Tharao W, Rebbapragada A, Huibner S, et al. Prevalence of sexually transmitted viral and bacterial infections in HIV-Positive and HIV-negative men who have sex with men in Toronto. PLoS One. 2016;11(7):e0158090. https://doi.org/10.1371/journal.pone.0158090

Issema R, Songster T, Edgar M, Davis B, Lee T, Harris J, et al. HIV-positive individuals who report being in care are less likely to be co-infected with an STI; an analysis of "Network Testing," a service program offering HIV and STI testing services to individual at risk for HIV. Open Forum Infect Dis. 2018;5 Suppl 1:S671-2. https://doi.org/10.1093/ofid/ofy210.1922

Hojilla JC, Marcus J, Volk JE, Leyden W, Hare CB, Hechter RC, et al. Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV. Sex Transm Infect. 2020;96(3):184-8. https://doi.org/10.1136/sextrans-2019-054049

Brignol S, Dourado I, Amorim LD, Kerr LRFS. Vulnerability in the context of HIV and syphilis infection in a population of men who have sex with men (MSM) in Salvador, Bahia State, Brazil. Cad Saude Publica. 2015;31(5):1035-48. https://doi.org/10.1590/0102-311X00178313

Shuper PA, Neuman M, Kanteres F, Baliunas D, Joarchi N, Rehm J. Causal considerations on alcohol and HIV /AIDS: a sistematic review. Alcohol Alcohol. 2010;45(2):159-66. https://doi.org/10.1093/alcalc/agp091

Kahler CW, Wray TB, Pantalone DW, Kruis RD, Mastroleo NR, Monti PM, et al. Daily associations between alcohol use and unprotected anal sex among heavy drinking HIV-positive men who have sex with men. AIDS Behav. 2014;19(3):422-30. https://doi.org/10.1007/s10461-014-0896-7

Hu QH, Xu JJ, Zou HC, Liu J, Zhang J, Ding HB, et al. Risk factors associated with prevalent and incident syphilis among an HIV-infected cohort in Northeast China. BMC Infect Dis. 2014;14:658. https://doi.org/10.1186/s12879-014-0658-1

Tsachouridou O, Skoura L, Christaki E, Kollaras P, Sidiropoulou E, Zebekakis P, et al. Syphilis on the rise: a prolonged syphilis outbreak among HIV-infected patients in Northern Greece. Germs. 2016;6(3):83-90. https://doi.org/10.11599/germs.2016.1093

Burchell AN, Allen VG, Gardner SL, Moravan V, Tan DHS, Grewal R, et al; OHTN Cohort Study Team. High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada. BMC Infect Dis. 2015;15:356. https://doi.org/10.1186/s12879-015-1098-2

Zoufaly A, Onyoh EF, Tih PM, Awasom CN, Feldt T. High prevalence of hepatitis B and syphilis co-infections among HIV patients initiating antiretroviral therapy in the north-west region of Cameroon. Int J STD AIDS. 2012;23(6):435-8. https://doi.org/10.1258/ijsa.2011.011279

Published

2022-06-24

Issue

Section

Original Articles

How to Cite

Simões, L. A. ., Mendes, J. C. ., Silveira, M. R. ., Costa, A. M. G. da ., Lula, M. D., & Ceccato, M. das G. B. . (2022). Factors associated with HIV/syphilis co-infection initiating of antiretroviral therapy. Revista De Saúde Pública, 56, 59. https://doi.org/10.11606/s1518-8787.2022056003904